| Net sales |
(3) |
1,816,192 |
1,676,695 |
1,420,563 |
1,298,877 |
395,629 |
377,818 |
| Cost of sales |
(4) |
1,279,787 |
1,290,801 |
882,351 |
909,853 |
397,436 |
380,948 |
| Gross profit on sales |
536,405 |
385,894 |
538,212 |
389,024 |
-1,807 |
-3,130 |
| Selling expenses |
380,533 |
375,919 |
375,472 |
370,555 |
5,061 |
5,364 |
| Research and development costs |
(12) |
35,598 |
48,744 |
35,598 |
48,744 |
- |
- |
| General administrative expenses |
26,549 |
27,543 |
26,549 |
27,543 |
- |
- |
| Other operating income |
(7) |
4,468 |
4,558 |
3,942 |
4,102 |
526 |
456 |
| Other operating expenses |
(8) |
3,655 |
8,552 |
3,653 |
8,434 |
2 |
118 |
| Income (loss) from companies accounted for using the equity method |
(16) |
3,056 |
-1,276 |
3,056 |
-1,276 |
- |
- |
| Other net income (loss) from investments |
(9) |
- |
-150 |
- |
-150 |
- |
- |
| Earnings before interest and income taxes |
97,594 |
-71,732 |
103,938 |
-63,576 |
-6,344 |
-8,156 |
| Financial income (loss) |
(10) |
-1,753 |
-2,749 |
-14,032 |
-12,265 |
12,279 |
9,516 |
| Earnings before taxes |
95,841 |
-74,481 |
89,906 |
-75,841 |
5,935 |
1,360 |
| Income taxes |
(11) |
13,502 |
-19,303 |
|
|
|
|
| Net income (loss) |
82,339 |
-55,178 |
|
|
|
|
| |
|
|
|
|
|
|
| Earnings per share in € (diluted / undiluted) |
(38) |
|
|
|
|
|
|
| Ordinary shares |
2.39 |
-1.65 |
|
|
|
|
| Preferred shares |
2.45 |
-1.59 |
|
|
|
|